insmed.com (INSM) Quarterly EPS earnings growth

Symbol and logo of brand Insmed Corp (INSM)

Insmed Incorporated (INSM) focuses on capturing a monopoly position in a niche segment through the launch of an innovative DPP1 inhibitor. This GURU.Markets chart displays the quarterly growth of net income per share, where the value is recorded at 73.80. The issuer's revenues rely on sales of its sole approved drug, while future success depends on FDA approvals and cost control.

INSM: Insmed Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/14/2026

Insmed Incorporated (INSM) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price insmed.com|INSM - Average Forecast Price
- market capitalization details:
Market Capitalization Insmed Inc.|INSM - Business Value
- balance sheet net asset value indicators:
Accounting Value per Share Insmed|INSM - Accounting Value of Company|Market Value to Book Value Ratio insmed.com|INSM - Total Asset Value of Company
- debt and solvency information:
Total Debt to Capital Insmed Incorporated|INSM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital insmed.com|INSM - Company Aggregate Debts|Debt to Book Capitalization Ratio Insmed Incorporated|INSM - Company Long-Term Loans and Borrowings|Company Short-Term Debt Insmed|Quick Ratio insmed.com
- earnings and valuation multiples information:
INSM - Net Profit|Projected Future Earnings Insmed Incorporated|INSM - Business Payback Period|Future Price to Earnings Insmed|INSM - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Insmed Inc.|INSM - Operating income before deduction of amortization|Earnings per share for the last twelve months Insmed|INSM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth insmed.com|INSM - Earnings per share growth rate in current year|Earnings growth forecast for next year Insmed Incorporated
- sales revenue and business income indicators:
INSM - Company Sales Volume|Company Future Sales Volume Insmed Inc|INSM - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Insmed Inc.
Initial company analysis:Insmed Incorporated
Flagship merchandise of Insmed Corp

Insmed Incorporated (INSM) seeks dominance in the treatment of rare respiratory pathologies through the expansion of orphan drugs and pipeline development. The quarterly change in earnings per share reflects the dynamics of net income attributable to a single security. This metric calculates the EPS growth rate, revealing the efficiency of operating expense management. Sharp spikes on this chart may signal temporary effects rather than systemic success. A stable trend confirms the business model's resilience to inflationary risks.

Who Insmed Incorporated competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|UTHR (United Therapeutics Corporation) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months BMRN (BioMarin)|Year-over-year net earnings per share growth for the last 12 months BBIO (BridgeBio)|BGM: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Year-over-year net earnings per share trend for the last twelve months|Keros Therapeutics - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months ARCT (Arcturus Therapeutics)|ETON: Quarterly EPS earnings growth|Kamada Ltd (KMDA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Fulcrum Tx|ABEO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Mereo BioPharma Group (MREO)|Quarterly EPS earnings growth protalix.com (PLX)|Quarterly EPS earnings growth PLRX (Pliant Therapeutics Inc)|Quarterly EPS earnings growth Applied Therapeutics APLT|RNTX - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Year-over-year net earnings per share growth for the last 12 months|Chemomab Therapeutics Ltd - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SRXH|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth